Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
12458 | 841 | 28.6 | 70% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1449 | 7299 | INTRAPERITONEAL CHEMOTHERAPY//CYTOREDUCTIVE SURGERY//PERITONEAL CARCINOMATOSIS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | INTRAPERITONEAL CHEMOTHERAPY | Author keyword | 42 | 26% | 17% | 140 |
2 | INTRAPERITONEAL | Author keyword | 8 | 16% | 6% | 47 |
3 | INTRAPERITONEAL THERAPY | Author keyword | 8 | 38% | 2% | 16 |
4 | INTRAPERITONEAL CATHETER | Author keyword | 6 | 80% | 0% | 4 |
5 | FLUID OSMOLARITY | Author keyword | 6 | 100% | 0% | 4 |
6 | CARRIER SOLUTIONS | Author keyword | 4 | 75% | 0% | 3 |
7 | IP CHEMOTHERAPY | Author keyword | 4 | 75% | 0% | 3 |
8 | INTRAPERITONEAL CARBOPLATIN | Author keyword | 1 | 100% | 0% | 2 |
9 | IP CATHETER | Author keyword | 1 | 100% | 0% | 2 |
10 | UVA CANC | Address | 1 | 33% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | INTRAPERITONEAL CHEMOTHERAPY | 42 | 26% | 17% | 140 | Search INTRAPERITONEAL+CHEMOTHERAPY | Search INTRAPERITONEAL+CHEMOTHERAPY |
2 | INTRAPERITONEAL | 8 | 16% | 6% | 47 | Search INTRAPERITONEAL | Search INTRAPERITONEAL |
3 | INTRAPERITONEAL THERAPY | 8 | 38% | 2% | 16 | Search INTRAPERITONEAL+THERAPY | Search INTRAPERITONEAL+THERAPY |
4 | INTRAPERITONEAL CATHETER | 6 | 80% | 0% | 4 | Search INTRAPERITONEAL+CATHETER | Search INTRAPERITONEAL+CATHETER |
5 | FLUID OSMOLARITY | 6 | 100% | 0% | 4 | Search FLUID+OSMOLARITY | Search FLUID+OSMOLARITY |
6 | CARRIER SOLUTIONS | 4 | 75% | 0% | 3 | Search CARRIER+SOLUTIONS | Search CARRIER+SOLUTIONS |
7 | IP CHEMOTHERAPY | 4 | 75% | 0% | 3 | Search IP+CHEMOTHERAPY | Search IP+CHEMOTHERAPY |
8 | INTRAPERITONEAL CARBOPLATIN | 1 | 100% | 0% | 2 | Search INTRAPERITONEAL+CARBOPLATIN | Search INTRAPERITONEAL+CARBOPLATIN |
9 | IP CATHETER | 1 | 100% | 0% | 2 | Search IP+CATHETER | Search IP+CATHETER |
10 | COMPUTED TOMOGRAPHIC PERITONEOGRAPHY | 1 | 40% | 0% | 2 | Search COMPUTED+TOMOGRAPHIC+PERITONEOGRAPHY | Search COMPUTED+TOMOGRAPHIC+PERITONEOGRAPHY |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | STAGE III OVARIAN | 84 | 68% | 9% | 73 |
2 | INTRAVENOUS CISPLATIN | 38 | 45% | 7% | 63 |
3 | IP CISPLATIN | 15 | 73% | 1% | 11 |
4 | RESIDUAL OVARIAN CANCER | 13 | 71% | 1% | 10 |
5 | INTRAVENOUS PACLITAXEL | 9 | 64% | 1% | 9 |
6 | REFRACTORY OVARIAN CARCINOMA | 9 | 83% | 1% | 5 |
7 | LIPID IMPLANT SYSTEM | 6 | 100% | 0% | 4 |
8 | DIFFERENT CARRIER SOLUTIONS | 4 | 75% | 0% | 3 |
9 | PACLITAXEL THERAPY | 4 | 46% | 1% | 6 |
10 | PERITONEALLY DISSEMINATED CANCER | 3 | 100% | 0% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Intraperitoneal chemotherapy in the first-line treatment of women with stage III epithelial ovarian cancer - A systematic review with melaanalyses | 2007 | 57 | 18 | 72% |
Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer | 2011 | 15 | 29 | 72% |
Ports and complications for intraperitoneal chemotherapy delivery | 2012 | 7 | 31 | 100% |
Intraperitoneal antineoplastic drug delivery: rationale and results | 2003 | 91 | 55 | 65% |
Intraperitoneal Drug Delivery for Ovarian Cancer: Why, How, Who, What, and When? | 2011 | 9 | 35 | 86% |
Principles and practice of intraperitoneal chemotherapy for ovarian cancer | 2007 | 28 | 66 | 82% |
Pharmacokinetics and Pharmacodynamics of Intraperitoneal Cancer Chemotherapeutics | 2012 | 13 | 155 | 56% |
Intraperitoneal carboplatin-based chemotherapy for epithelial ovarian cancer | 2005 | 37 | 11 | 73% |
Intraperitoneal therapy of ovarian cancer | 1998 | 51 | 13 | 85% |
Intraperitoneal chemotherapy in the management of patients with advanced epithelial ovarian cancer: a critical review of the literature | 2008 | 11 | 87 | 89% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | UVA CANC | 1 | 33% | 0.4% | 3 |
2 | EASTERN REG MED | 1 | 40% | 0.2% | 2 |
3 | CANC GYNECOL ONCOL | 1 | 50% | 0.1% | 1 |
4 | CITY HOSP NOTTINGHAM NHS TRUST | 1 | 50% | 0.1% | 1 |
5 | CLIN INVEST CIC | 1 | 50% | 0.1% | 1 |
6 | DON SYBIL HARRINGTON CANC | 1 | 50% | 0.1% | 1 |
7 | GYNECOL TUMOR SERV | 1 | 50% | 0.1% | 1 |
8 | INSERM 9408 | 1 | 50% | 0.1% | 1 |
9 | MS RAMAIAH CURIE ONCOL | 1 | 50% | 0.1% | 1 |
10 | OBSTET GYNECOL L GO A GEMELLI 8 | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000233592 | PLATINUM RESISTANT//RECURRENT OVARIAN CANCER//PEGYLATED LIPOSOMAL DOXORUBICIN |
2 | 0.0000228653 | PSEUDOMYXOMA PERITONEI//HIPEC//PERITONEAL CARCINOMATOSIS |
3 | 0.0000129291 | INTERVAL DEBULKING SURGERY//SECONDARY CYTOREDUCTIVE SURGERY//ADVANCED OVARIAN CANCER |
4 | 0.0000083566 | CALVERT FORMULA//CHATELUT FORMULA//SKI 2053R |
5 | 0.0000074627 | OREGOVOMAB//AFLIBERCEPT//GI PERFORATION |
6 | 0.0000068578 | ACTIVATED CARBON PARTICLES//LYMPH NODE TARGETING//LYMPHATIC TARGETING |
7 | 0.0000067935 | PERITONEAL LAVAGE CYTOLOGY//J AN FOOD EDUC HLTH//PERITONEAL CYTOLOGY |
8 | 0.0000066690 | NEPHROTOXICITY//SERV FARMACOL TOSSICOL//CISPLATIN NEPHROTOXICITY |
9 | 0.0000065637 | MCA RH7777//LIVER ANGIOGRAPHY//INTERVENT RADIOL RADIOL |
10 | 0.0000063113 | LIPOSOMAL CISPLATIN//LIPOPLATIN//SPI 077 |